The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
Open accessAbstract
BACKGROUND: Fine-needle aspiration (FNA) cytology is a common approach to evaluate thyroid nodules. It offers definitive diagnosis of a benign or malignant nodule in the majority of cases. However, 10-25% of nodules yield one of three indeterminate cytologic diagnoses, leading to suboptimal management of these patients. Atypia of undetermined significance/follicular lesion of undermined significance (AUS/FLUS) is a common indeterminate diagnosis, with the cancer risk ranging from 6% to 48%. This study assessed whether a multi-gene next-generation sequencing (NGS) assay can offer significant improvement in diagnosis in AUS/FLUS nodules. METHODS: From May 2014 to March 2015, 465 consecutive FNA samples with the cytologic diagnosis of AUS/FLUS underwent prospective molecular testing using the ThyroSeq v2.1 panel. The panel included 14 genes analyzed for point mutations and 42 types of gene fusions occurring in thyroid cancer. In addition, eight genes were assessed for expression in order to evaluate the cell composition of FNA samples. Ninety-eight (21%) of these nodules had definitive surgical (n = 96) or nonsurgical (n = 2) follow-up and were used to determine the assay performance. RESULTS: Among 465 AUS/FLUS nodules, three were found to be composed of parathyroid cells and 462 of thyroid follicular cells. Of the latter, 31 (6.7%) were positive for mutations. The most frequently mutated genes were NRAS and HRAS, and overall point mutations in seven different genes and five types of gene fusions were identified in these nodules. Among 98 nodules with known outcome, histologic analysis revealed 22 (22.5%) cancers. ThyroSeq v2.1 was able to classify 20/22 cancers correctly, showing a sensitivity of 90.9% [confidence interval (CI) 78.8-100], specificity of 92.1% [CI 86.0-98.2], positive predictive value of 76.9% [CI 60.7-93.1], and negative predictive value of 97.2% [CI 78.8-100], with an overall accuracy of 91.8% [CI 86.4-97.3]. CONCLUSIONS: The results of the study demonstrate that the ThyroSeq v2.1 multi-gene NGS panel of molecular markers provides both high sensitivity and high specificity for cancer detection in thyroid nodules with AUS/FLUS cytology, which should allow improved management for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationThe Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2009) · Thyroid · doi:10.1089/thy.2009.0274 · Cited by 1,261
Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal
Gharib, H., & Goellner, J. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00007 · Cited by 1,193
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
Alexander, E. K., Kennedy, G. C., Baloch, Z. W., Cibas, E. S., Chudova, D., Diggans, J., Friedman, L., Kloos, R. T., LiVolsi, V. A., Mandel, S. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203208 · Cited by 1,163
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Bongiovanni, M., Spitale, A., Faquin, W. C., Mazzucchelli, L., & Baloch, Z. W. (2012) · Acta Cytologica · doi:10.1159/000339959 · Cited by 1,032
Baloch, Z. W., LiVolsi, V. A., Asa, S. L., Rosai, J., Merino, M. J., Randolph, G., Vielh, P., DeMay, R. M., Sidawy, M. K., & Frable, W. J. (2008) · Diagnostic Cytopathology · doi:10.1002/dc.20830 · Cited by 880
Nikiforov, Y. E., Ohori, N. P., Hodak, S. P., Carty, S. E., LeBeau, S. O., Ferris, R. L., Yip, L., Seethala, R. R., Tublin, M. E., Stang, M. T., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1469 · Cited by 790
Self-citationNikiforova, M. N., Lynch, R. A., Biddinger, P. W., Alexander, E. K., Dorn, G. W., Tallini, G., Kroll, T. G., & Nikiforov, Y. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021907 · Cited by 713
Self-citationYang, J., Schnadig, V., Logrono, R., & Wasserman, P. G. (2007) · Cancer · doi:10.1002/cncr.22955 · Cited by 685
The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes
(2010) · Springer eBooks · doi:10.1007/978-0-387-87666-5 · Cited by 507
Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., Hodak, S. P., LeBeau, S. O., Ohori, N. P., et al. (2014) · Cancer · doi:10.1002/cncr.29038 · Cited by 500
Self-citationNayar, R., & Ivanovic, M. (2009) · Cancer Cytopathology · doi:10.1002/cncy.20029 · Cited by 325
Ferris, R. L., Baloch, Z., Bernet, V., Chen, A., Fahey, T. J., Ganly, I., Hodak, S. P., Kebebew, E., Patel, K. N., Shaha, A., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0502 · Cited by 222
Self-citationClinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations
VanderLaan, P. A., Marqusee, E., & Krane, J. F. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp4p2gccdnhfmy · Cited by 221
McIver, B., Castro, M. R., Morris, J. C., Bernet, V., Smallridge, R., Henry, M., Kosok, L., & Reddi, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3584 · Cited by 215
Role of repeat fine‐needle aspiration biopsy (FNAB) in the management of thyroid nodules
Baloch, Z., LiVolsi, V. A., Jain, P., Jain, R., Aljada, I., Mandel, S., Langer, J. E., & Gupta, P. K. (2003) · Diagnostic Cytopathology · doi:10.1002/dc.10361 · Cited by 171
Ohori, N. P., & Schoedel, K. E. (2011) · Acta Cytologica · doi:10.1159/000334218 · Cited by 158
Self-citationKim, S. K., Hwang, T. S., Yoo, Y. B., Han, H. S., Kim, D., Song, K., Lim, S. D., Kim, W. S., & Paik, N. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1082 · Cited by 137
Vitagliano, D., Portella, G., Troncone, G., Francione, A., Rossi, C., Bruno, A., Giorgini, A., Coluzzi, S., Nappi, T. C., Rothstein, J. L., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209527 · Cited by 76
Adeniran, A., Hui, P., Chhieng, D. C., Prasad, M. L., Schofield, K., & Theoharis, C. (2011) · Acta Cytologica · doi:10.1159/000333274 · Cited by 66
Cited by
Cabanillas, M. E., McFadden, D. G., & Durante, C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30172-6 · Cited by 1,430
Biologic and Clinical Perspectives on Thyroid Cancer
Fagin, J. A., & Wells, S. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1501993 · Cited by 990
The Diagnosis and Management of Thyroid Nodules: A Review
Durante, C., Grani, G., Lamartina, L., Filetti, S., Mandel, S. J., & Cooper, D. S. (2018) · JAMA · doi:10.1001/jama.2018.0898 · Cited by 803
Haugen, B. R. (2017) · Cancer · doi:10.1002/cncr.30360 · Cited by 683
Steward, D. L., Carty, S. E., Sippel, R. S., Yang, S. P., Sosa, J. A., Sipos, J. A., Figge, J. J., Mandel, S., Haugen, B. R., Burman, K. D., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4616 · Cited by 486
Self-citation
Metadata
- Authors
- Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., Coyne, C., Duvvuri, U., Ferris, R. L., Gooding, W. E., LeBeau, S. O., Ohori, N. P., Seethala, R. R., Tublin, M. E., Yip, L., & Nikiforova, M. N.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2015-11
- Volume
- 25
- Issue
- 11
- Pages
- 1217-1223
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2109174925
- Cited by
- 394
- References
- 20
- FWCI
- 46.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.